Sleep drug may increase risk of falls, study finds

11/20/2012 | U.S. News & World Report

Mayo Clinic researchers examined data on more than 16,000 hospitalized patients in the U.S., and found that those who received the sleeping pill Ambien, or zolpidem, fell at a rate four times greater than those who didn't receive the treatment. Due to the research, Mayo is transitioning to other sleep-enhancement treatments, said Dr. Timothy Morgenthaler, Mayo's chief patient safety officer.

View Full Article in:

U.S. News & World Report

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC